title: Epigenetic mechanisms of mouse interstrain variability in genotoxicity of the environmental toxicant 1,3-butadiene.
abstract: 1,3-Butadiene (BD) is a common environmental contaminant classified as "carcinogenic to humans." Formation of BD-induced DNA adducts plays a major role in its carcinogenicity. BD is also an epigenotoxic agent (i.e., it affects DNA and histone methylation in the liver). We used a panel of genetically diverse inbred mice (NOD/LtJ, CAST/EiJ, A/J, WSB/EiJ, PWK/PhJ, C57BL/6J, and 129S1/SvImJ) to assess whether BD-induced genotoxic and epigenotoxic events may be subject to interstrain differences. Mice (male, 7 weeks) were exposed via inhalation to 0 or 625 ppm BD for 6 h/day and 5 days/week for 2 weeks and liver BD-DNA adducts, epigenetic alterations, and liver toxicity were assessed. N-7-(2,3,4-trihydroxybut-1-yl)-guanine adducts were detected in all strains after exposure, yet BD-induced DNA damage in CAST/EiJ mice was two to three times lower. Epigenetic effects of BD were most prominent in C57BL/6J mice where loss of global DNA methylation and loss of trimethylation of histone H3 lysine 9, histone H3 lysine 27, and histone H4 lysine 20, accompanied by dysregulation of liver gene expression indicative of hepatotoxicity, were found. Interestingly, we observed an increase in histone methylation in the absence of changes in gene expression and DNA methylation in CAST/EiJ strain. We hypothesized that mitigated genotoxicity of BD in CAST/EiJ mice may be due to chromatin condensation. Indeed, we show that in response to BD exposure, chromatin condensation occurs in CAST/EiJ, whereas the opposite effect is observed in C57BL/6J mice. These findings demonstrate that interstrain susceptibility to genotoxicity by a well-known environmental carcinogen may be due to strain-specific epigenetic events in response to the exposure.
authors: Division of Biochemical Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, Arkansas 72079, USA.
authors: Igor
authors: I
authors: Koturbash
authors: Anne
authors: A
authors: Scherhag
authors: Jessica
authors: J
authors: Sorrentino
authors: Kenneth
authors: K
authors: Sexton
authors: Wanda
authors: W
authors: Bodnar
authors: James A
authors: JA
authors: Swenberg
authors: Frederick A
authors: FA
authors: Beland
authors: Fernando
authors: F
authors: Pardo-Manuel Devillena
authors: Ivan
authors: I
authors: Rusyn
authors: Igor P
authors: IP
authors: Pogribny
references: Mamm Genome. 2008 Jun;19(6):382-9
references: 18716833
references: Nat Genet. 2011 May 29;43(7):648-55
references: 21623374
references: Genome Res. 2011 Aug;21(8):1213-22
references: 21406540
references: Toxicol Sci. 2011 Mar;120(1):206-17
references: 21135412
references: Carcinogenesis. 1994 Apr;15(4):713-7
references: 8149485
references: Cancer Res. 2008 Sep 1;68(17):6863-72
references: 18757397
references: Mutat Res. 2010 Oct;705(2):83-95
references: 20399890
references: Toxicology. 1996 Oct 28;113(1-3):306-9
references: 8901914
references: Chem Biol Interact. 2007 Mar 20;166(1-3):93-103
references: 16616907
references: EMBO J. 2005 Feb 23;24(4):800-12
references: 15678104
references: Environ Health Perspect. 1993 Oct;101(5):402-6
references: 8119248
references: Biochim Biophys Acta. 2008 Dec;1783(12):2398-414
references: 18706456
references: Biol Cell. 2004 Oct;96(8):631-7
references: 15519697
references: FEBS J. 2006 Jul;273(14):3121-35
references: 16857008
references: Chem Biol Interact. 2011 Jun 30;192(1-2):150-4
references: 20974116
references: Mutagenesis. 2009 Mar;24(2):117-25
references: 19033256
references: Proc Natl Acad Sci U S A. 1994 Feb 15;91(4):1361-5
references: 8108416
references: Crit Rev Toxicol. 2009;39(6):449-61
references: 19545196
references: Nat Rev Genet. 2004 Jun;5(6):446-55
references: 15153997
references: Genome Res. 2009 Sep;19(9):1507-15
references: 19416960
references: Nature. 1998 Sep 3;395(6697):89-93
references: 9738504
references: Science. 2002 Nov 1;298(5595):1039-43
references: 12351676
references: Toxicol Appl Pharmacol. 2010 Sep 15;247(3):211-21
references: 20621112
references: Environ Health Perspect. 2009 May;117(5):685-95
references: 19479008
references: Carcinogenesis. 2006 Aug;27(8):1713-20
references: 16632870
references: Drug Metab Dispos. 2001 Jun;29(6):830-6
references: 11353751
references: Cell. 2007 Feb 23;128(4):683-92
references: 17320506
references: Mol Cancer. 2010 Mar 31;9:70
references: 20356374
references: Natl Toxicol Program Tech Rep Ser. 1993 May;434:1-389
references: 12616297
references: EXS. 2009;99:259-88
references: 19157065
references: Mutat Res. 2000 Jan 3;464(1):77-86
references: 10633179
references: Science. 2010 Oct 22;330(6003):460-1
references: 20966241
references: Biochem Biophys Res Commun. 1999 Sep 7;262(3):624-8
references: 10471374
references: Risk Anal. 2009 Apr;29(4):485-7; discussion 492-7
references: 19076321
references: Methods. 2001 Dec;25(4):402-8
references: 11846609
references: Environ Health Perspect. 2011 May;119(5):635-40
references: 21147608
references: Environ Mol Mutagen. 2008 Jan;49(1):9-15
references: 17879298
references: Pharmacogenomics. 2010 Aug;11(8):1127-36
references: 20704464
references: Environ Health Perspect. 1998 Oct;106(10):623-7
references: 9755136
references: Nat Rev Cancer. 2004 Aug;4(8):630-7
references: 15286742
references: Curr Protoc Mol Biol. 2010 Jan;Chapter 21:Unit 21.17.1-16
references: 20069538
references: Chem Res Toxicol. 1999 Jul;12(7):566-74
references: 10409395
references: Natl Toxicol Program Tech Rep Ser. 1984 Aug;288:1-111
references: 12748715
references: Toxicol Sci. 2009 Jul;110(1):235-43
references: 19420014
references: Nucleic Acids Res. 2008 Oct;36(17):5678-94
references: 18772227
references: Nat Rev Mol Cell Biol. 2005 Nov;6(11):838-49
references: 16261189